Company profile: Calviri
1.1 - Company Overview
Company description
- Provider of cancer vaccines and diagnostics combining the immunogenic source of neoantigens with a peptide array platform, including a preventative vaccine targeting cancer-causing agents, a diagnostic blood test detecting immune responses to tumor-specific neoantigens, and a therapeutic vaccine stimulating the immune system to attack existing cancer.
Products and services
- Diagnostic: Peptide-array-based blood test that detects immune responses to tumor-specific neoantigens, indicating the presence of cancer by combining immunogenic neoantigen sources with a peptide array platform
- Preventative Vaccine: Neoantigen-targeted vaccine that aims to prevent cancer by neutralizing specific cancer-causing agents before disease initiation, leveraging immunogenic neoantigen sources and a peptide array platform to guide antigen selection
- Therapeutic Vaccine: Peptide-array-informed therapeutic vaccine that treats existing cancer by stimulating the immune system to attack cancer cells via tumor-specific neoantigen recognition
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Calviri
Labcyte
HQ: United States
Website
- Description: Provider of Echo Acoustic Liquid Handling systems and laboratory instrumentation for life sciences applications, using focused acoustic energy to eject nanoliter-scale droplets from one plate to another with high accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labcyte company profile →
Altar
HQ: France
Website
- Description: Provider of biotechnology solutions in automated fluidics, developing and operating proprietary technologies that bring microbes to performance suitable for commercial use. Serves customers leveraging microorganisms to produce food, feed, flavors & fragrances, cosmetics, and fuels.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Altar company profile →
Ion Torrent
HQ: United States
Website
- Description: Provider of sequencing technology that enables a direct connection between chemical and digital information; the first commercial PostLight sequencing technology that doesn't use light. Ion Torrent is a wholly-owned subsidiary of Life Technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ion Torrent company profile →
LEAP Technologies
HQ: Australia
Website
- Description: Provider of micro dispensing, PAL accessories, support, and repair services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LEAP Technologies company profile →
Anterios
HQ: United States
Website
- Description: Provider of botulinum-based prescription products for aesthetic medicine and dermatology and nanotechnology-based delivery systems for administering drugs and cosmetics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anterios company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Calviri
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Calviri
2.2 - Growth funds investing in similar companies to Calviri
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Calviri
4.2 - Public trading comparable groups for Calviri
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →